EDWARDS LIFESCIENCES CORP. REGISTERED SHARES DL 1
Technische Signale
| Signale Details | |
|---|---|
| WKN / ISIN | - / US28176E1082 |
| Börse | Xetra |
| Schluss | 59,78 |
| Konservatives Signal |  29.08.24 |
| MACD | 28.08.24 |
| Momentum | 26.06.24 |
| Bollinger Bands |  06.08.24 |
| TBI | 27.08.24 |
| Schnitt GD 90 | 20.06.24 |
Analystenbewertung
| Bewertungstrend | aktuell | Vorwoche | Vormonat |
|---|---|---|---|
| Bewertung | 2,35 | 2,29 | 2,29 |
| Anzahl der Analysten | 31 | 31 | 31 |
| Kaufen | 8 | 9 | 9 |
| Übergewichten | 5 | 5 | 5 |
| Halten | 17 | 16 | 16 |
| Untergewichten | 1 | 1 | 1 |
| Verkaufen | 0 | 0 | 0 |
| Aktueller Durchschnitt von insgesamt 31 Analysten: 2,35 | |||
| Planzahlen (in EUR) | 2023 | 2024(e) | 2025(e) |
|---|---|---|---|
| Umsatz | 6,00 Mrd. | 5,96 Mrd. | 7,17 Mrd. |
| EBIT | 1,39 Mio. | 1,90 Mrd. | 2,17 Mrd. |
| EBITDA | 1,52 Mio. | 2,06 Mrd. | 2,33 Mrd. |
| Nettoverschuldung** | -1.202.310.000 | -1.670.810.000 | -2.802.390.000 |
Umsatz |
EBIT |
EBITDA |
Nettoverschuldung** |
| Dividende | 2023 | 2024(e) | 2025(e) |
|---|---|---|---|
| Dividende / Aktie | 0,00 EUR | 0,00 USD | 0,00 USD |
| Dividendenrendite | 0,00% | 0,00% | 0,00% |
Dividende / Aktie (in USD) |
Dividendenrendite (in %) |
||
| Analystenhäuser |
|---|
| Atlantic Equities LLP,Baird,Baptista Research,Barclays,BMO Capital Markets Equity Research,BMO Capital Markets U.S. (Historical),BofA Global Research,Brean Capital,BTIG,Canaccord Genuity,Capstone Investments,Caris & Company,CFRA Equity Research,China International Capital Corporation Limited,Citigroup Inc,Cleveland Research Company,Craig-Hallum Capital Group LLC,Credit Suisse,CRT Capital Group,Daiwa Securities Co. Ltd.,Deutsche Bank,Equisights,Evercore ISI,Financiële Diensten Amsterdam,G. Research, LLC,GARP Research & Securities Co.,Goldman Sachs,Guggenheim Securities, LLC,J.P. Morgan,Janney Montgomery Scott LLC,Jefferies LLC,JMP Securities,Lazard Capital Markets,Leerink Partners LLC,Madison Williams and Company LLC,Mirae Asset Securities Co., Ltd.,Mizuho Securities USA LLC,Morgan Joseph TriArtisan LLC,Morgan Keegan & Company,Morgan Stanley,Morningstar Inc.,Natixis Bleichroeder Inc.,NOBLE Capital Markets, Inc.,Nomura Securities Co. Ltd.,Northland Capital Markets,Oppenheimer & Co. Inc.,Piper Sandler Companies,Raymond James & Associates,RBC Capital Markets,Redburn Atlantic,Rodman & Renshaw, LLC,Sanford C. Bernstein & Co., LLC,Sterne Agee & Leach,Stifel, Equities Research,TD Cowen,ThinkEquity LLC,Truist Securities,UBS Investment Bank,Wedbush Securities Inc.,Wells Fargo Securities, LLC,William Blair & Company L.L.C.,Wolfe Research, LLC.,Wunderlich Securities Inc.,Zephirin Group, Inc. |
| Hinweis |
|---|
|
Selected Data supplied by Standard & Poors
* Unabhängige Schätzung (Gewinnwachstum (in %)) ** Nettobargeldbestand bei negativen Schätzungen |